BioAgilytix, a leading provider of contract bioanalytical testing services with specialization in large molecule bioanalysis, is expanding its advanced bioanalytical technology suite with the addition of Sword Bio’s detection platform for immunoassays. The companies will collaborate to meet ever-growing customer needs to further enhance the performance of immunoassays used for biomarkers, immunogenicity, and pharmacokinetics (PK).